D89.832 ICD-10-CM Code: Cytokine release syndrome, grade 2
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) / Certain disorders involving the immune mechanism (D80-D89)
D89.832
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceCytokine release syndrome, grade 2
Cytokine release syndrome grade 2 is a moderate immune system reaction where the body releases excessive inflammatory chemicals (cytokines), typically occurring as a side effect of certain cancer treatments or immunotherapies. This grade involves moderate symptoms that may require medical intervention but are not immediately life-threatening.
CMS-HCC V28
00
RAF 0
CMS-HCC V24
00
RAF 0
ACA/HHS
00
RAF 0
ESRD/PACE
00
RAF 0
RXHCC
00
RAF 0
Code Trumping
Basket needed
Code Book Path
Inclusion Terms
OfficialICD-10-CM does not list inclusion terms for D89.832 in this effective period.
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for D89.832 in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for D89.832 in this effective period.
Excludes 1
OfficialICD-10-CM does not list Excludes 1 notes for D89.832 in this effective period.
Code First
Official- underlying cause, such as:
- complications following infusion, transfusion and therapeutic injection (T80.89-)
- complications of transplanted organs and tissue (T86.-)
Use Additional
Official- code for adverse effect, if applicable, to identify immune checkpoint inhibitors and immunostimulant drugs (T45.AX5)
Code Also
OfficialICD-10-CM does not list Code Also instructions for D89.832 in this effective period.
Buddy Documentation Tip
Last updated: FY2026 ICD-10-CM Apr update, Apr 1, 2026 through Sep 30, 2026. CMS-HCC V28 is 100% phased in for payment year 2026.
Is D89.832 an HCC code?
No. D89.832 is a billable ICD-10-CM code but does not map to any HCC category in V28, V24, ESRD, or RxHCC.
Coder workflow notes
Get the V28 RAF + MEAT cheat sheet
One printable page: confirm a code's V28 HCC status, its RAF weight, and the MEAT your note needs to make it stick. Free, no card.
Free PDF. No card. Unsubscribe anytime.
This code does not map to an HCC category in any model (V28, V24, ESRD, RxHCC).
What This Code Means
D89.832 is the ICD-10-CM diagnosis code for cytokine release syndrome, grade 2. Cytokine release syndrome grade 2 is a moderate immune system reaction where the body releases excessive inflammatory chemicals (cytokines), typically occurring as a side effect of certain cancer treatments or immunotherapies. This grade involves moderate symptoms that may require medical intervention but are not immediately life-threatening. D89.832 sits in the ICD-10-CM chapter for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (d50-d89), within the section covering certain disorders involving the immune mechanism (d80-d89).
D89.832 is a billable ICD-10-CM code but does not map to a payment HCC under the CMS-HCC V28, V24, ESRD, or RxHCC risk adjustment models. It can be reported on Medicare Advantage encounter data submissions but it does not contribute to a beneficiary's RAF score and therefore does not affect risk-adjusted payments to the plan.
This code is commonly associated with CAR-T cell therapy, checkpoint inhibitors, and monoclonal antibody treatments—always verify the triggering medication or treatment in the clinical documentation.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for D89.832 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •This code is commonly associated with CAR-T cell therapy, checkpoint inhibitors, and monoclonal antibody treatments—always verify the triggering medication or treatment in the clinical documentation
- •Grade 2 CRS requires careful distinction from grades 1, 3, and 4 as each has different severity levels and treatment implications; review clinical notes for symptom severity (fever, hypotension, organ dysfunction) to ensure correct grade assignment